Norepinephrine Induces PTSD-Like Memory Impairments via Regulation of the β-Adrenoceptor-cAMP/PKA and CaMK II/PKC Systems in the Basolateral Amygdala

Glucocorticoids (GCs) can modulate the memory enhancement process during stressful events, and this modulation requires arousal-induced norepinephrine (NE) activation in the basolateral amygdale (BLA). Our previous study found that an intrahippocampal infusion of propranolol dose-dependently induced...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in behavioral neuroscience Vol. 13; p. 43
Main Authors Liu, Xiang-Hui, Zhu, Rong-Ting, Hao, Bo, Shi, Yan-Wei, Wang, Xiao-Guang, Xue, Li, Zhao, Hu
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Research Foundation 06.03.2019
Frontiers Media S.A
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Glucocorticoids (GCs) can modulate the memory enhancement process during stressful events, and this modulation requires arousal-induced norepinephrine (NE) activation in the basolateral amygdale (BLA). Our previous study found that an intrahippocampal infusion of propranolol dose-dependently induced post-traumatic stress disorder (PTSD)-like memory impairments. To explore the role of the noradrenergic system of the BLA in PTSD-like memory impairment, we injected various doses of NE into the BLA. We found that only a specific quantity of NE (0.3 μg) could induce PTSD-like memory impairments, accompanied by a reduction in phosphorylation of GluR1 at Ser845 and Ser831. Moreover, this phenomenon could be blocked by a protein kinase A (PKA) inhibitor or calcium/calmodulin-dependent protein kinase II (CaMK II) inhibitor. These findings demonstrate that NE could induce PTSD-like memory impairments regulation of the β-adrenoceptor receptor (β-AR)-3',5'-cyclic monophosphate (cAMP)/PKA and CaMK II/PKC signaling pathways.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors have contributed equally to this work
Edited by: Israel Liberzon, University of Michigan Health System, United States
Reviewed by: Piray Atsak, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Netherlands; Rafael Roesler, Universidade Federal do Rio Grande do Sul (UFRGS), Brazil
ISSN:1662-5153
1662-5153
DOI:10.3389/fnbeh.2019.00043